Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.

Abstract

Combined analysis of cytokeratin 7 (CK7) and cytokeratin 20 (CK20) is often used for assessing the origin of metastatic cancer. To evaluate the diagnostic utility of CK7 and CK20, tissue microarrays containing 15,424 samples from 120 different tumor types and subtypes and 608 samples of 76 different normal tissue types were analyzed by immunohistochemistry. CK7 positivity was seen in 52% (8.7% weak, 5.9% moderate, 37% strong) and CK20 positivity in 23% (5.1% weak, 3.4% moderate, 15% strong) of interpretable tumors. Of 8390 positive tumors, 1181 (14%) showed positivity for CK7 and CK20, 5380 (64%) showed positivity for CK7 alone, and 1829 (22%) showed positivity for CK20 alone. CK20 predominated in gastrointestinal tract, urothelial and Merkel cell carcinomas. CK7 was usually negative in prostate cancer and colorectal cancer. Combined evaluation of CK7/CK20 revealed the best diagnostic utility in CK20 positive tumors, where CK7 negativity is often linked to colorectal origin while CK7 positivity argues for urothelial origin or mucinous ovarian cancer. Associations with unfavorable tumor features were found for cytokeratin 7 loss in breast cancer of no special type, urothelial and renal cell carcinomas, for CK7 overexpression in high-grade serous ovarian and gastric cancer, and for CK20 overexpression in urothelial carcinoma. CK20 loss was linked to MSI in gastric (p = 0.0291) and colorectal adenocarcinoma (p < 0.0001). These analyses provide comprehensive data on the frequency of CK7 and CK20 immunostaining - alone or in combination - in human cancers. These data facilitate interpretation of CK7/CK20 immunostaining in cancers.

• Authors: David Dum, Anne Menz, Cosima Völkel, Noémi De Wispelaere, Andrea Hinsch, Natalia Gorbokon, Maximilian Lennartz, Andreas M Luebke, Claudia Hube-Magg, Martina Kluth, Christoph Fraune, Katharina Möller, Christian Bernreuther, Patrick Lebok, Till S Clauditz, Frank Jacobsen, Guido Sauter, Ria Uhlig, Waldemar Wilczak, Stefan Steurer, Sarah Minner, Andreas H Marx, Ronald Simon, Eike Burandt, Till Krech
• Journal: Experimental and molecular pathology (Exp Mol Pathol) Vol. 126 Pg. 104762 (06 2022) ISSN: 1096-0945 [Electronic] Netherlands
• PMID: 35390310 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Chemical References

• Biomarkers, Tumor
• Intermediate Filament Proteins
• Keratin-20
• Keratin-7
• Keratins

Topics

• Biomarkers, Tumor (metabolism)
• Carcinoma, Transitional Cell (genetics, metabolism, pathology)
• Colorectal Neoplasms (genetics, metabolism, pathology)
• Humans
• Intermediate Filament Proteins (genetics, metabolism)
• Keratin-20 (genetics, metabolism)
• Keratin-7 (genetics, metabolism)
• Keratins (analysis, metabolism)
• Male
• Urinary Bladder Neoplasms (genetics, metabolism)